Conference
Durable Efficacy and Manageable Safety in Patients Aged ≥75 Years With Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL) Treated With Tisagenlecleucel in the Real-World Setting
Authors
Landsburg DJ; Heim M; Moskop A; Foley SR; Hill BT; Schofield G; Jacobson CA; Jaglowski S; Locke FL; Ram R
Volume
24
Pagination
pp. S471-S471
Publisher
CIG MEDIA GROUP, LP
Publication Date
September 1, 2024
Conference proceedings
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
ISSN
2152-2650